Biogen (BIIB) Debt Ratio (2009 - 2026)
Biogen (BIIB) posted quarterly Debt Ratio of 0.25 for Q2 2026, up 11.03% year-over-year from 0.23 in Q2 2025, and up 18.21% quarter-over-quarter from 0.21 in Q1 2026.
Biogen (BIIB) Debt Ratio (2009 - 2026) Analysis & Trends
Biogen's Debt Ratio history runs 18 years deep, the most recent figure standing at 0.25 for Q2 2026.
- In Q2 2026, Debt Ratio rose 11.03% year-over-year to 0.25; the TTM figure through Jun 2026 stood at 0.25 (up 11.03% YoY), while the FY2025 annual figure was 0.21, down 4.86% from the prior year.
- Debt Ratio for Q2 2026 stood at 0.25, up from 0.21 in the prior quarter.
- The five-year high for Debt Ratio was 0.31 in Q1 2022, with the low at 0.21 in Q1 2026.
- The 5-year median for Debt Ratio is 0.24 (2023), against an average of 0.24.
- The sharpest annual moves came in 2022 and 2026: Debt Ratio declined 17.28% in 2022, then gained 11.03% in 2026.
- Biogen's Debt Ratio stood at 0.26 in 2022, then gained by 1.04% to 0.26 in 2023, then dropped by 13.16% to 0.22 in 2024, then declined by 4.86% to 0.21 in 2025, then rose by 18.07% to 0.25 in 2026.
- Business Quant data shows BIIB's Debt Ratio at 0.25 in Q2 2026, 0.21 in Q1 2026, and 0.21 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.81 Bn | 632.06 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 470.36 Bn | 463.79 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 375.71 Bn | 368.57 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 303.50 Bn | 295.81 Bn | 11.24 Bn | 0.08 |
| 5 | Astrazeneca | 257.38 Bn | 252.48 Bn | 12.86 Bn | 0.25 |
| 6 | Amgen | 236.44 Bn | 222.45 Bn | 7.24 Bn | 0.66 |
| 7 | Gilead Sciences | 181.93 Bn | 178.75 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.38 Bn | 147.68 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.17 Bn | 102.00 Bn | 8.24 Bn | -0.31 |
| 10 | Biogen | 32.03 Bn | 30.74 Bn | 1.96 Bn | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.25 |
| Mar 31, 2026 | 0.21 |
| Dec 31, 2025 | 0.21 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 0.22 |
| Dec 31, 2024 | 0.22 |
| Sep 30, 2024 | 0.22 |
| Jun 30, 2024 | 0.23 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | 0.26 |
| Sep 30, 2023 | 0.24 |
| Jun 30, 2023 | 0.25 |
| Mar 31, 2023 | 0.26 |
| Dec 31, 2022 | 0.26 |
| Sep 30, 2022 | 0.25 |
| Jun 30, 2022 | 0.29 |
| Mar 31, 2022 | 0.31 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | 0.31 |